BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6185150)

  • 21. [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro].
    Ino Y; Suzuki K; Sato T; Iwaki M
    Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):449-55. PubMed ID: 2435641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
    Berling R; Borgström A; Ohlsson K
    Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolytic enzyme activity in patients with severe head injury and the effect of a proteinase inhibitor.
    Auer LM; Marth E; Heppner F; Holasek A
    Acta Neurochir (Wien); 1979; 49(3-4):207-17. PubMed ID: 92877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic fibrosis alpha 2-macroglobulin protease interaction in vitro.
    Parsons M; Romeo G
    Clin Chim Acta; 1980 Jan; 100(3):215-24. PubMed ID: 6153299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
    Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
    J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro interactions of rat pancreatic elastase and normal and inflammatory ray serum.
    Gauthier F; Genell S; Mouray H; Ohlsson K
    Biochim Biophys Acta; 1978 Sep; 526(1):218-26. PubMed ID: 80233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protease activation following reperfusion of porcine pancreatic allografts.
    Källén R; Montgomery A; Borgström A
    J Surg Res; 1992 Nov; 53(5):495-501. PubMed ID: 1279275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interactions between human blood serum inhibitors and native and modified dextran proteinases--terrilytin and trypsin].
    Lindenbaum GM; Tereshin IM
    Biokhimiia; 1978 Dec; 43(12):2143-9. PubMed ID: 84689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
    Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
    Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Levels of alpha 1-antitrypsin and alpha 2-macroglobulin in blood serum and its antitryptic capacity].
    Protsenko VA; Veselov VF; Protsenko AV; Kiriukhin IF; Kosik OG
    Ukr Biokhim Zh (1978); 1982; 54(4):377-82. PubMed ID: 6182660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutral proteases of human granulocytes. IV. Interaction between human granulocyte collagenase and plasma protease inhibitors.
    Ohlsson K; Olsson I
    J Lab Clin Med; 1977 Feb; 89(2):269-77. PubMed ID: 64576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiproteinase activity of alpha 2-macroglobulin].
    Protsenko AV
    Ukr Biokhim Zh (1978); 1984; 56(5):546-9. PubMed ID: 6209837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease inhibitors in porcine serum and their immunological relationships to human protease inhibitors.
    Weström BR
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1861-7. PubMed ID: 93563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protease inhibitors in rheumatoid synovial fluid. Analyses of electrophoretic homogeneity and protease inhibitory capacity.
    Ekerot L; Ohlsson K
    Rheumatol Int; 1982; 2(1):21-6. PubMed ID: 6184771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats.
    Gabryelewicz A; Kosidlo S; Prokopowicz J; Podkowicz K
    Hepatogastroenterology; 1986 Apr; 33(2):79-82. PubMed ID: 2424815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gabexate mesilate (FOY) and aprotinin. A comparative study of the effects on trypsin-induced activation of the kinin and complement systems in vivo and in vitro.
    Lasson A; Balldin G; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1984 Dec; 365(12):1409-15. PubMed ID: 6084637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of chemical modification on proteinase interaction with inhibitors, on their coagulability and acute toxicity].
    Bogacheva TI; Mirgorodskaia OA; Grinberg GE; Mikhaĭlets GA; Moskvichev BV
    Biokhimiia; 1981 May; 46(5):863-71. PubMed ID: 6170349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated nonproteolytic cleavage of C3 in plasma from patients with primary biliary cirrhosis.
    Lindgren S
    J Lab Clin Med; 1989 Dec; 114(6):655-61. PubMed ID: 2531785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intramolecular general acid catalysis in the binding reactions of alpha 2-macroglobulin and complement components C3 and C4.
    Davies SG; Sim RB
    Biosci Rep; 1981 Jun; 1(6):461-8. PubMed ID: 6170356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low levels of functional of alpha 1-proteinase inhibitor in the promotion of C3-cleavage by granulocyte-neutral proteases in pleural empyema.
    Suter S; Berger D; Despont JP; Waldvogel F
    J Infect Dis; 1984 Jun; 149(6):935-41. PubMed ID: 6203992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.